US2003229200A1PendingUtilityA1
Selective linear peptides with melanocor tin-4 receptor (MC4-R) agonist activity
Priority: Apr 4, 2000Filed: May 9, 2003Published: Dec 11, 2003
Est. expiryApr 4, 2020(expired)· nominal 20-yr term from priority
C07K 5/1016A61P 3/04A61P 5/00C07K 14/68C07K 7/06A61K 38/00A61P 43/00
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Peptides of formulae I, II and III that selectively activate melanocortin-4 (MC-4) receptor activity.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A compound of the formula:
wherein
m is 0 or 1;
n is 0 or 1;
R 1 is an unsubstituted linear or branched alkyl having from 1 to 8 carbon atoms; linear or branched alkyl having from 1 to 8 carbon atoms mono-substituted by phenyl or carboxyl; unsubstituted phenyl; or phenyl mono-substituted by fluoro, chloro or linear or branched alkyl having from 1 to 4 carbon atoms;
X is
wherein R 2 , R 3 and R 4 are independently hydrogen or a linear or branched alkoxy having from 1 to 4 carbon atoms, wherein when R 3 is alkoxy, R 2 and R 4 are both hydrogen;
R 9 is hydrogen, linear or branched alkyl having from 1 to 3 carbons, linear or branched alkoxy having from 1 to 3 carbons, or unsubstituted phenoxy;
R 11 is cyclohexyl, cycloheptyl, or a branched alkyl having from 3 to 8 carbon atoms;
R 6 is hydrogen or methyl;
R 7 is
Y is
and R 8 is hydrogen or methyl; or
Y is
and R 8 is hydrogen.Join the waitlist — get patent alerts
Track US2003229200A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.